• 1
    Mathew A, Devesa SS, Fraumeni JF, Jr, et al. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 2002; 11: 171178.
  • 2
    Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci 2010; 25: 11131121.
  • 3
    Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 2011; 105 Suppl 1: S52S73.
  • 4
    WCRF. World Cancer Research Fund. Food, nutrition, physical activity, and the prevention of cancer: a global perspective, 2nd edn. Washington: American Institute for Cancer Research, 2007.
  • 5
    Cho E, Adami HO, Lindblad P. Epidemiology of renal cell cancer. Hematol Oncol Clin North Am 2011; 25: 651665.
  • 6
    Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer – a quantitative review. Br J Cancer 2001; 85: 984990.
  • 7
    Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 16251638.
  • 8
    Awakura Y, Nakamura E, Ito N, et al. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology 2007; 70: 5054.
  • 9
    Jeon HG, Jeong IG, Lee JH, et al. Prognostic value of body mass index in Korean patients with renal cell carcinoma. J Urol 2010; 183: 448454.
  • 10
    Cho HJ, Kim SJ, Ha US, et al. Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma. Eur Urol 2009; 56: 10061012.
  • 11
    Lee WK, Byun SS, Kim HH, et al. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study. Int J Urol 2010; 17: 898904.
  • 12
    Komura K, Inamoto T, Black PC, et al. Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma. Nutr Cancer 2011; 63: 908915.
  • 13
    Parker AS, Lohse CM, Cheville JC, et al. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 2006; 68: 741746.
  • 14
    Schrader AJ, Rustemeier J, Rustemeier JC, et al. Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. J Cancer Res Clin Oncol 2009; 135: 16931699.
  • 15
    Waalkes S, Merseburger AS, Kramer MW, et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 2010; 21: 19051910.
  • 16
    Kovacs G, Akhtar M, Beckwith BJ, et al. The heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131133.
  • 17
    Greene F, Page D, Fleming I. AJCC cancer staging manual 6th edn. New York, NY: Springer-Verlag, 2002.
  • 18
    Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655663.
  • 19
    Fritz A, Percy C, Jack A, ed. International classification of diseases for oncology, 3rd edn. Geneva: World Health Organization, 2000.
  • 20
    Korean National Statistics Office: Korean statistical information service. Available at:, August 10, 2011 accessed.
  • 21
    Korean National Statistics Office. Annual report on the cause of death statistics (based on vital registration), Daejeon: Korean National Statistics Office, 2010, pp. 254.
  • 22
    Korean National Statistics Office. Korea Standard Classification of Cause of Death (KCD), Seoul: 3rd revision: Korean National Statistics Office, 1995.
  • 23
    World Health Organization. International classifications of diseases and related health problems: manual of the international statistical classification of diseases, injuries, and causes of death, 10th edn. Geneva: World Health Organization, 1992.
  • 24
    Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, the International Obesity Task Force: The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia, Health Communications Australia Pty Limited, 2000.
  • 25
    Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008; 9 Suppl 1: 5361.
  • 26
    Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than caucasians? Redefining obesity for Asians. Public Health Nutr 2009; 12: 497506.
  • 27
    Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3: 141146.
  • 28
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177188.
  • 29
    Schips L, Lipsky K, Zigeuner R, et al. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients. J Surg Oncol 2004; 88: 57: 61; discussion 61–62.
  • 30
    Pettus JA, Jang TL, Thompson RH, et al. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc 2008; 83: 11011106.
  • 31
    Gabr AH, Gdor Y, Strope SA, et al. Patient and pathologic correlates with perioperative and long-term outcomes of laparoscopic radical nephrectomy. Urology 2009; 74: 635640.
  • 32
    Morgan TM, Tang D, Stratton KL, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 201; 59: 923928.
  • 33
    Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557560.
  • 34
    Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629634.
  • 35
    Yu ML, Asal NR, Geyer JR. Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer 1991; 68: 16481655.
  • 36
    Donat SM, Salzhauer EW, Mitra N, et al. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. J Urol 2006; 175: 4652.
  • 37
    Haferkamp A, Pritsch M, Bedke J, et al. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int 2008; 101: 12431246.
  • 38
    Naya Y, Zenbutsu S, Araki K, et al. Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma. Urol Int 2010; 85: 3036.
  • 39
    Ha US, Hwang TK, Kim YJ, et al. Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clear-cell renal cell carcinoma: a multi-institutional study. BJU Int 2011; 107: 14671472.
  • 40
    Kamat AM, Shock RP, Naya Y, et al. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 2004; 63: 4650.
  • 41
    Luo JH, Zhou FJ, Xie D, et al. Analysis of long-term survival in patients with localized renal cell carcinoma: Laparoscopic versus open radical nephrectomy. World J Urol 2010; 28: 289293.
  • 42
    Ather MH, Nazim SM. Impact of Charlson's comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma. Int Urol Nephrol 2010; 42: 299303.
  • 43
    Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579591.
  • 44
    Vredevoe DL, Woo MA, Doering LV, et al. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 82: 323328.
  • 45
    Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 2935.